New Enterprise Associates led a $300m Series D round in Strive Health.

New Enterprise Associates, a venture capital firm, led a $300m Series D round in Strive Health, a provider of value-based kidney care, with participation from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures and Redpoint. "The continued investments from NEA, Strive’s founding capital partner, alongside a syndicate of leading financial institutions combined with valued tech and healthcare strategics, is a clear signal that the Strive team is delivering on that mission. By transforming kidney care, we will ultimately make the healthcare system work better for patients and provider," Chris Riopelle, Strive Health Co-Founder and CEO.